You have 9 free searches left this month | for more free features.

City

Rehovot (2)

Petach Tikva (1)

Washington (1)

Condition

Acute Myelogenous Leukemia (1)

Cancer (1)

KRAS Mutation-Related Tumors (1)

Myelodysplastic Syndromes (1)

Solid Tumor (1)

Overall Status

Completed (1)

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Immune System Key Ltd (2)

Georgetown University (1)

Collaborator

Immune System Key Ltd (1)

Intervention

nerofe (3)

doxorubicin (2)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

nerofe

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Solid Tumor, KRAS Mutation-Related Tumors Trial in Washington (NEROFE, Doxorubicin)

Recruiting

Solid Tumor
KRAS Mutation-Related Tumors

NEROFE
Doxorubicin

Washington, District of Columbia

Georgetown Lombardi Comprehensive Cancer Center

Jan 23, 2023

Acute Myelogenous Leukemia, MDS Trial in Petach Tikva, Re?ovot (Nerofe, Doxorubicin)

Withdrawn

Acute Myelogenous Leukemia
Myelodysplastic Syndromes

Nerofe
Doxorubicin

Petach Tikva, Israel
+1 more

Jul 29, 2020

Cancer Trial in Rehovot (Nerofe)

Completed

Cancer

Nerofe

Rehovot, Israel

Kaplan Medical Center

Jun 21, 2018